Related Experiment Video
Updated: Jun 27, 2026
07:37
Transpupillary-Guided Trans-Scleral Transplantation of Subretinal Grafts in a Retinal Degeneration Mouse Model
Published on: January 26, 2024
Transplantation prospects for the inner retina.
T V Johnson1, N D Bull, K R Martin
1Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Eye (London, England)
|December 23, 2008
Summary
Stem cell transplantation shows promise for treating neurodegenerative central nervous system diseases. Intraocular cell injections offer potential neuroprotection and neuronal replacement for inner retinal diseases like glaucoma.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Ophthalmology
Background:
- Stem and progenitor cell transplantation is a promising strategy for neurodegenerative diseases.
- Retinal cell replacement, particularly for retinal ganglion cells, presents significant challenges in establishing neural connections.
- Neuroprotective applications of cell therapy are anticipated to reach clinical use sooner than replacement strategies.
Purpose of the Study:
- To review the potential benefits of intraocular cell transplantation for inner retinal diseases.
- To evaluate the efficacy of various cell types, including Müller stem cells (MIO-M1), oligodendrocyte precursor cells (OPCs), and mesenchymal stromal cells (MSCs), in a rat glaucoma model.
- To discuss current limitations and future research directions for retinal stem cell therapy.
Main Methods:
- Investigation of intraocular cell transplantation for neuronal replacement or neuroprotection in inner retinal disease.
- Experimental transplantation of human Müller stem cells (MIO-M1), OPCs, and MSCs in a rat model of induced glaucoma.
- Development and characterization of an in vitro organotypic retinal explant culture system to enhance cell transplantation efficacy.
Main Results:
- The study explored the efficacy and effects of transplanting MIO-M1, OPCs, and MSCs in a rat glaucoma model.
- A novel in vitro retinal explant culture system was developed to optimize cell transplantation methods.
- The review discusses the potential benefits of intraocular cell injections for retinal diseases.
Conclusions:
- Intraocular cell transplantation holds potential for treating inner retinal diseases through neuroprotection or neuronal replacement.
- Challenges remain in achieving successful retinal ganglion cell replacement due to the complexity of neural connections.
- Further research is needed to overcome shortcomings and advance retinal stem cell therapy, with neuroprotection potentially preceding replacement therapies clinically.
